New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors Problem: “Breast density is in the eye of the mammographer”

How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer

It is rare that an ABC Movie of the Week endures. Buzz Kulik’s 1971 “Brian’s Song” is a notable exception.

September 27, 2024

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Jose and Irma Russo dedicated their careers to investigating breast cancer, its causes, and potential prevention measures.

September 27, 2024

Vol.50 No.36

In Brief

UMich Rogel Cancer Center receives $25M from Weiser Charitable Foundation

Drs. Melissa Pilewskie (left) and Monika Burness, co-leads of the Weiser Family Center for Breast CancerPhoto credit: Michigan MedicineThe Weiser Charitable Foundation donated $25 million to support the establishment the Weiser Family Center for Breast Cancer at the University of Michigan Health Rogel Cancer Center.

September 27, 2024

Vol.50 No.36

Clinical Roundup

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

The NRG Oncology NSABP B-39/RTOG 0413 clinical trial compared whole-breast irradiation to accelerated partial-breast irradiation and determined that APBI was not statistically equivalent to WBI in local tumor control. The secondary outcome for the trial was quality-of-life.

September 20, 2024

Vol.50 No.35

Drugs & Targets

FDA approves Kisqali + aromatase inhibitor for early high-risk breast cancer

FDA approved Kisqali (ribociclib) with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage 2 and 3 early breast cancer at high risk of recurrence.

September 20, 2024

Vol.50 No.35

Obituary

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

Richard A. Rettig, the author of an authoritative history of the writing of the National Cancer Act of 1971, died on Aug. 7.

September 13, 2024

Vol.50 No.34

By Paul Goldberg

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors

Problem: “Breast density is in the eye of the mammographer”

YOU MAY BE INTERESTED IN

How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

UMich Rogel Cancer Center receives $25M from Weiser Charitable Foundation

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

FDA approves Kisqali + aromatase inhibitor for early high-risk breast cancer

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login